- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06194357
Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers
Developing an Integrated Mindfulness-based Health Qigong Intervention (iMBHQ) for COVID-19 Survivors and Caregivers to Improve Their Physical and Psychological Wellness
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective:
The study aims to examine whether iMBHQ can improve the physical and psychological wellness of COVID-19 survivors, caregivers and the general public in the community.
Procedures:
Participants will be randomized into either the treatment group (16-week iMBHQ program) or the control group. For the treatment group, a face-to-face initial session will be arranged for each participant to introduce the practice of the most essential skills, particularly mindfulness, the basic movements of Qigong and the use of the resources package. Following the initial session, participants will kick off 8 bi-weekly online sessions of MBIs approximately two hours each via the Mobile App. Afterwards, participants will be asked to practice Qigong for 30 minutes per day with five days weekly for another 8 weeks. Follow-up sessions will be conducted by an experienced coach via the Mobile App. After the first 16-week intervention, booster sessions will be provided every 3 months to revise the interventions and follow-up assessments will be completed every 6 months for 2 years.
Participants:
will be asked to practice Qigong for 30 minutes per day with five days weekly for another 8 weeks. Follow-up sessions will be conducted by an experienced coach via the Mobile App. After the first 16-week intervention, booster sessions will be provided every 3 months to revise the interventions and follow-up assessments will be completed every 6 months for 2 years.
Results:
The investigators predict that the integrated intervention developed will significantly reduce fear, anxiety and stigma in COVID-19 survivors, their caregivers and the general public by improving stress, cognitive, and mood coping strategies.
Conclusions:
The findings will be able to explain the effects and outcomes of integrated intervention derived from the hypothetical model which the investigators will propose. The outcomes will also help transform the hypothetical model into a psychosocial and rehabilitation theory, which can explain many of the psychosocial and behavioral consequences that may hinder the recovery of those affected by COVID-19 and hinder their caregivers and the general public to seek help and take preventive measures against the disease. The findings will also demonstrate that the integrated intervention developed by the research group will be the long-term and cost-effective rehabilitation management approaches for COVID-19 survivors, caregivers, and the general public to promote their physical and psychological wellbeing in the community
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Travis,Tsz-kwun Law, Mr
- Phone Number: 29901017
- Email: tk120@ha.org.hk
Study Locations
-
-
-
Hong Kong, Hong Kong, 852
- Recruiting
- Princess Margaret Hospital
-
Contact:
- Travis,Tsz-kwun Law, Mr
- Phone Number: (852)29901017
- Email: tk120@ha.org.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- COVID-19 survivors: people aged 18 years or above who were infected by COVID-19 (both symptomatic and asymptomatic) and clinically recovered
- Caregivers of COVID-19 patients, including family members or medical professionals who have contacts with patients diagnosed COVID-19 aged 18 years or above
- General healthy public aged 18 years or above
Exclusion Criteria:
- people diagnosed severe and/or chronic conditions that prevent the practice of Qigong (e.g., acute exacerbation of dyspnoea, severe cardiopulmonary disease) or mindfulness intervention,
- people with severe psychiatric disorder
- people who have regular psychiatric follow-ups
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Intervention group will receive training on Qigong exercise and mindfulness.
|
Participants are introduced the practice of the most essential skills, particularly mindfulness, the basic movements of Qigong and the use of the resources package.
Following the initial session, participants will kick off 8 bi-weekly online sessions of Mindfulness-based interventions approximately two hours each via the Mobile App.
Afterwards, participants will be asked to practice Qigong for 30 minutes per day with five days weekly for another 8 weeks.
Follow-up sessions will be conducted by an experienced coach via the Mobile App.
After the first 16-week intervention, booster sessions will be provided every 3 months to revise the interventions and follow-up assessments will be completed every 6 months for 2 years.
|
|
No Intervention: Control group
Control group will not receive intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological wellbeing
Time Frame: 2 years
|
Depression, Anxiety and Stress Scale (DASS-12)
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Time Frame: 2 years
|
12-item Short Form healthy survey (SF-12); Rumination Reflection Questionnaire (RRQ); Hyperarousal Scale COVID-19 Fear Scale; Stigma: Perceived stigma and Self-stigma Scale; Attitudes toward rapid testing and vaccine scale
|
2 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Wing Hong, Hector TSANG, Prof, Department of Rehabilitation Science, Faculty of Health and Social Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KW/EX-23-001(179-01)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19 Infection
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
Aga Khan UniversityCompletedCOVID-19 Respiratory Infection | COVID-19 Pandemic | COVID-19 Lower Respiratory InfectionPakistan
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOVID-19 | Coronavirus Disease 2019 | COVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress Syndrome | COVID-19 Acute Bronchitis | COVID-19 Lower Respiratory InfectionUnited States
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingCOVID-19 Vaccine | COVID-19 Respiratory Infection | SARS CoV 2 InfectionUnited States
-
Catalysis SLCompletedRespiratory Tract Infections | Covid19 | SARS-CoV2 Infection | COVID-19 Pneumonia | COVID-19 Respiratory Infection | Viral Infection | Infection, CoronavirusKazakhstan
-
KARE BiosciencesBiomedical Advanced Research and Development Authority; BioLink Life Sciences... and other collaboratorsRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory InfectionIndia
-
AudibleHealth AI, Inc.Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaboratorsCompletedCoronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV DiseaseUnited States
-
bioLytical LaboratoriesCompletedCOVID-19 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19United States
-
Tiziana Life Sciences LTDWithdrawnCovid19 | COVID-19 Respiratory Infection | COVID-19 Lower Respiratory Infection
Clinical Trials on Mindfulness-based Health Qigong Intervention
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Chung Shan Medical UniversityChanghua Christian HospitalUnknownWeight Loss | Health Promotion | Mindfulness | WorkplaceTaiwan
-
Singapore General HospitalCompletedDepression | Stroke | Stress | AnxietySingapore
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of PittsburghNational Institute of Mental Health (NIMH)Active, not recruiting
-
University of PittsburghNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedSexual Dysfunction | Female Sexual Dysfunction | Hypoactive Sexual Desire DisorderUnited States
-
University of BarcelonaUniversity Ramon Llull; ICREA Academia; Institut de Neurociències de la Universitat... and other collaboratorsRecruiting
-
Linda E. CarlsonAlberta Health services; University of Calgary; Princess Margaret Hospital, Canada and other collaboratorsActive, not recruiting
-
Singapore General HospitalCompletedDepression | Stroke | Stress | AnxietySingapore
-
Xiaofan YanCompletedMilitary Personnel With High PressureChina